2024 Annual Meeting | H56 - Generative Artificial Intelligence versus Clinicians: Who Diagnoses Disease Faster and with Greater Accuracy? (Innovation Hub)

Date Sunday 04/14/24

Time 01:15 PM - 01:45 PM MDT Add To Calendar

Location Colorado Convention Center | Exhibit Hall B-E

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Innovation)

Director(s) Darin T. Okuda, MD, FAAN, Mahi Patel

Topic(s) General Neurology

Learning Objectives In today’s world where generative artificial intelligence (AI) platforms have gained rapid popularity, healthcare providers should be made aware of resources that patients and family members may be using and the influence on healthcare. This presentation aims to address this need by identifying how patients may be utilizing technology for healthcare outside of interacting with doctors face-to-face. During this presentation, the audience will gain an understanding of the leading users (Generation Z) of Generative AI platforms (ChatGPT), learn about innate biases that may be present involving distinct groups, and obtain insights on the capabilities of Generative AI and the implications on the future of healthcare. Audience members will also be able to actively engage with a generative AI platform in real-time during the session.

CME Available No CME available

Program Tracks Artificial Intelligence

Program Materials Program Evaluations

Event Timeline
01:15 PM - 01:45 PM MDT	Speaker	Generative Artificial Intelligence versus Clinicians: Who Diagnoses Disease Faster and with Greater Accuracy? Darin T. Okuda, MD, FAAN, Mahi Patel

Faculty Disclosures
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RVL Pharmaceuticals, Inc.. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas BioPharma. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from EMD Serono. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Mahi Patel	Ms. Patel has nothing to disclose.